Cruse Michael

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Cruse Michael's trades of Onkure Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-02 2022-09-01
B Purchase
69,091 -21.3%
440.24
US$3,673,958 		69,091 -21.3% 440.24 US$3,673,958
2022-08-31 2022-08-31
B Purchase
22,613 -39.2%
399.61
US$566,646 		22,613 -39.2% 399.61 US$566,646
2022-08-31 2022-08-30
B Purchase
44,573 -17.7%
271.05
US$2,289,428 		44,573 -17.7% 271.05 US$2,289,428
2022-08-31 2022-08-30
B Purchase
975 +3.2%
3.16
US$3,081 		975 +3.2% 3.16 US$3,081
2022-08-31 2022-08-29
B Purchase
1,140 +inf%
3.24
US$3,694 		1,140 +inf% 3.24 US$3,694
2022-08-31 2022-08-29
PP Planned purchase
83 +0.3%
3.24
US$269 		83 +0.3% 3.24 US$269